WebDisclosure WebDisclosure
Basculer en Français
9472 Companies
185370 Keywords
117721 Articles
99262 Press releases
Headlines Articles Press releases ScriptDrop Remove
  1. Home
  2. Companies
  3. ScriptDrop
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 02/27/2024 at 16:00, 1 year 9 months ago

    ScriptDrop et Louvir s'associent pour améliorer l'accès aux médicaments

    ScriptDrop Louvir Accès Aux Médicaments Livraison De Prescriptions Programme 340B
  • BRIEF

    published on 02/27/2024 at 16:00, 1 year 9 months ago

    ScriptDrop and Louvir partner to improve access to medicines

    ScriptDrop Louvir Access To Medicines Prescription Delivery 340B Program
  • PRESS RELEASE

    published on 02/27/2024 at 16:00, 1 year 9 months ago

    ScriptDrop Inc. and Louvir Partner to Simplify Prescription Access for Patients

    ScriptDrop, Inc. partners with Louvir to provide same-day and next-day prescription delivery, improving medication access for 340B patients. Partnership aims to boost medication adherence and revenue
    Louvir Prescription Delivery ScriptDrop Inc. Medication Access 340B Patients
    Logo of ScriptDrop
Accesswire
  • Published on 12/05/2025 at 02:35, 5 hours 32 minutes ago

    Future Fuels Initates Drill Permitting at Hornby; Marketing Update

  • Published on 12/05/2025 at 02:30, 5 hours 37 minutes ago

    Klondike Gold Announces AGM Results

  • Published on 12/05/2025 at 01:00, 7 hours 7 minutes ago

    BEACN Closes First Tranche of Non-Brokered Private Placement

  • Published on 12/04/2025 at 23:05, 9 hours 2 minutes ago

    BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025

  • Published on 12/04/2025 at 23:00, 9 hours 7 minutes ago

    NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE
EQS Group
  • Published on 12/05/2025 at 07:00, 1 hour 7 minutes ago

    Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business

  • Published on 12/05/2025 at 03:30, 4 hours 37 minutes ago

    CGTN: What makes cooperation between China and France a two-way success

  • Published on 12/04/2025 at 23:50, 8 hours 16 minutes ago

    EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes

  • Published on 12/04/2025 at 20:25, 11 hours 42 minutes ago

    Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions

  • Published on 12/04/2025 at 20:15, 11 hours 52 minutes ago

    Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025

View all EQS
Les Echos
  • Published on 12/04/2025 at 18:14, 13 hours 52 minutes ago

    Résiliation d'une convention conclue entre actionnaires

  • Published on 12/04/2025 at 18:00, 14 hours 7 minutes ago

    Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025

  • Published on 12/04/2025 at 18:00, 14 hours 7 minutes ago

    Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025

  • Published on 12/04/2025 at 17:45, 14 hours 22 minutes ago

    Informations relatives au nombre total de droits de vote et d’actions

  • Published on 12/04/2025 at 17:45, 14 hours 22 minutes ago

    MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2025 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy